Ebola virus disease
Sierra Leone one year on
9 June 2017 -- Today, Sierra Leone marks the one year anniversary of the end of the Ebola outbreak. The country is working to build back stronger, more resilient health systems, after the worst Ebola outbreak in history. This photo story shows how WHO-supported mothers' groups are playing an important role in bringing women and their families back to health services and clinics.
13 May 2017 - The WHO Regional Director for Africa, Dr Matshidiso Moeti today visited Kinshasa to discuss with national authorities and partners ways to mount a rapid, effective and coherent response in order to stop the ongoing Ebola outbreak.
5 May 2017 -- More than 11 000 people in Guinea participated in a WHO-led trial to develop the world’s first vaccine against Ebola virus disease. The ground-breaking trial, which ended in January 2016, resulted in a vaccine that is highly protective against the deadly virus. Dr Margaret Chan, Director-General of WHO, visited some of the communities who participated in the vaccine trial in the city of Conakry.
4 May 2017 -- “The world is far better prepared for another Ebola outbreak,” said Dr Margaret Chan, WHO Director-General, today at a celebratory event to recognize the Governments and people of the three most-affected countries for their contribution to the control of the Ebola outbreak in 2014-2015.
Sharing lessons from a milestone year: WHO Sierra Leone's 2016 Progress Report
March 2017 -- WHO continues to support countries like Sierra Leone, that were struck by the Ebola outbreak: prevent, detect, and respond to epidemics and ensure zero cases of Ebola Virus Disease (EVD); and deliver continuous care for Ebola-affected persons and survivors.
23 December 2016 – An experimental Ebola vaccine was highly protective against the deadly virus in a major trial, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year. The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11 841 people in Guinea during 2015.
Situation reports: DRC
Review of the situation and an assessment of the response measured against the core indicators. The reports include tables, maps, and data on total number of Ebola cases in the Democratic Republic of Congo.
- Key technical documents on Ebola
- Clinical care for survivors of Ebola virus disease
- Surveillance strategy during Phase 3 of the Ebola response
- Recovery toolkit: Supporting countries to achieve health service resilience
- Ebola response phase 3: Framework for achieving and sustaining a resilient zero
- Infection prevention and control guidance for care of patients in health-care settings, with focus on Ebola
Past outbreaks of Ebola in DRC
Press briefing on Ebola virus disease in the Democratic Republic of the Congo
WHO Regional Director for Africa, Dr Matshidiso Moeti travels to Kinshasa to discuss Ebola outbreak response